Found 0 matching trials
Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA โฅ 90% PHASE4 This study is a prospective, open-label, two-arm exploratory clinical trial...
Show More Location
Multiple Locations
Learn More & Join Trial
Infusion of Allogeneic, 3rd Party CD19-specific T Cells PHASE1 The goal of this clinical research study is to learn if researchers can suc...
Show More Location
Multiple Locations
Learn More & Join Trial
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes PHASE1 The purpose of this study is to evaluate the safety, efficacy and blood kin...
Show More Location
Jichi Medical University
Learn More & Join Trial
CD19-Specific T Cells Post AlloSCT PHASE1 This phase I trial investigates the side effects and best dose of CD19 posi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia PHASE1 This phase I trial studies the side effects and best dose of cellular immun...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies PHASE1 Sometimes researchers change the DNA (genetic material in cells) of donated...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis PHASE2 RESET-SSc: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy...
Show More Learn More & Join Trial
Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies PHASE1 This study is a multi-center study to evaluate the safety of KUR-502 in sub...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies N/A This is a non-interventional observational study aiming to evaluate the qua...
Show More Location
Seoul St. Mary Hospital
Learn More & Join Trial
Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia PHASE1 This is a Phase I clinical study evaluating the safety and maximum tolerate...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial